Top Markets
#1 Akedo Akedo +195.32%
#2 ONFA ONFA +54.15%
#3 Talus Network Talus Network +27.78%
#4 Osaka Protocol Osaka Protocol +21.37%
#5 0G 0G +21.23%
#6 Metaplex Metaplex +20.26%
#7 Wrapped Krown Wrapped Krown +19.97%
#8 EVAA Protocol EVAA Protocol +18.16%
#9 eCash eCash +15.89%
#10 Unibase Unibase +15.04%
Coin of the day
Akedo Akedo
設定
言語
日本
通貨
USD
テーマ
Pfizer Inc. Pfizer Inc.

Pfizer Inc.

PFE
株式のランク #146
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells... Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
株価
$24.25
時価総額
$138.21B
変化（1日）
-0.94%
変化（1年）
194.85%
国
US
取引 Pfizer Inc. (PFE)

カテゴリー

Healthcare
Pfizer Inc.（PFE）のP/B比率
2026 時点のP/B比率 TTM: 0
Pfizer Inc. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Pfizer Inc. の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 33.0453 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.6457 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 15.7899 -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 6.509 -
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 7.4763 -
CH